Schedule 13G ownership disclosure
Fennec Pharmaceuticals Inc
Security class unavailable · CUSIP: 31447P100
Event date: 2024-05-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-24-025449
- Form type
- SC 13G
- Filer
- DG Capital Management, LLC
- CIK
- CIK 1512716
- Filed
- Jun 27, 2024
- Reporting period
- May 14, 2024
- Description
- Schedule 13G beneficial ownership